Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

Plasma Lipid Profile Reveals Plasmalogens as Potential Biomarkers for Colon Cancer Screening

In this era of precision medicine, there is an increasingly urgent need for highly sensitive tests for detecting tumors such as colon cancer (CC), a silent disease where the first symptoms may take 10–15 years to appear. Mass spectrometry-based lipidomics is an emerging tool for such clinical diagno...

Full description

Bibliographic Details
Main Authors: Anna Maria A.P. Fernandes, Marcia C.F. Messias, Gustavo H.B. Duarte, Gabrielle K.D. de Santis, Giovana C. Mecatti, Andreia M. Porcari, Michael Murgu, Ana Valéria C. Simionato, Thalita Rocha, Carlos A.R. Martinez, Patricia O. Carvalho
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Metabolites
Subjects:
colon cancer
biomarkers
lipidomic
mass spectrometry
plasmalogens
Online Access:https://www.mdpi.com/2218-1989/10/6/262

Internet

https://www.mdpi.com/2218-1989/10/6/262

Similar Items